About
Functional and motility gastrointestinal disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
281
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06500429Lead Sponsor
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
PHASE2Completed
120 participants
Started: Jun 24, 2024 · Completed: Sep 13, 2024
NCT04303195Lead Sponsor
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
PHASE2Completed
161 participants
Started: Aug 1, 2020 · Completed: Feb 25, 2023
Locations (1)
Headquarters
Woburn, MA, United States
Map
Loading map...